Ke Sai - Concepedia

Author

Ke Sai

Also Known As

K Sai, K Siva Krishna Sai, K. Hema Sai, K. Rathan Sai, K. Sai, K. Satya Sai,, K.Shiva Sai, KE SAI, Kancharla Nititsh Sai, Ke Sai

122

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Sun Yat-sen University Sun Yat-sen University Cancer Center State Key Laboratory of Oncology in South China Guangzhou Medical University Capital Medical University

About

Ke Sai is an author at Sun Yat-sen University specializing in medicine, glioma, and neuro-oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	1.5K
2	Health Sciences	7	7	736
3	Engineering	2	2	37
4	Biochemistry	1	1	14
5	Biomedical Engineering	1	1	15

Ke Sai

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
CGCG clinical practice guidelines for the management of adult diffuse gliomas Tao Jiang, Ying Mao, Wenbin Ma, Cancer Letters Neuro-oncologyRadiation OncologyClinical NeurosurgeryMedicineCancer Management	2016	647
Clinical practice guidelines for the management of adult diffuse gliomas Tao Jiang, Do‐Hyun Nam, Zvi Ram, Cancer Letters Neuro-oncologyGliomaMedicineDiagnostic NeuroradiologyNeurology	2020	454
Clinical significance of vasculogenic mimicry in human gliomas Xiao-mei Liu, Qing-ping Zhang, Yong-gao Mu, Journal of Neuro-Oncology	2011	143
The Anti-Warburg Effect Elicited by the cAMP-PGC1α Pathway Drives Differentiation of Glioblastoma Cells into Astrocytes Fan Xing, Yizhao Luan, Jing Cai, Cell Reports	2017	122
miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1 Jie Wang, Ke Sai, Fu‐Rong Chen, Cancer Chemotherapy and Pharmacology Neuro-oncologyGliomaMedicineMir-181b ModulatesCancer Cell Biology	2013	70
Induction of cell-cycle arrest and apoptosis in glioblastoma stem-like cells by WP1193, a novel small molecule inhibitor of the JAK2/STAT3 pathway Ke Sai, Shuzhen Wang, Veerakumar Balasubramaniyan, Journal of Neuro-Oncology Neuro-oncologySignaling PathwayGliomaReceptor Tyrosine KinaseJak2/stat3 Pathway	2012	69
TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cells Jia Fu, Qun Yang, Ke Sai, Neuro-Oncology	2013	67
Dihydroartemisinin increases temozolomide efficacy in glioma cells by inducing autophagy ZE-SHUN ZHANG, Jing Wang, YOU-BI SHEN, Oncology Letters	2015	63
MiR-181b sensitizes glioma cells to teniposide by targeting MDM2 Yan-chang Sun, Jing Wang, Chengcheng Guo, BMC Cancer	2014	62
R406 elicits anti-Warburg effect via Syk-dependent and -independent mechanisms to trigger apoptosis in glioma stem cells Shuxin Sun, Dongdong Xue, Zhijie Chen, Cell Death and Disease	2019	58

Page 1